Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 9:22 PM ET

Pharmaceuticals

Company Overview of Piramal Enterprises Limited

Executive Profile

Peter De Young

President of NCE, Piramal Enterprises Limited
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Peter De Young serves as President of NCE at Piramal Enterprises Limited. Mr. De Young serves as a Director of Ascendancy Healthcare, Inc. Mr. De Young is jointly responsible for the NCE Research division of Piramal Enterprises, Piramal Life Sciences. His specific responsibilities in the NCE Research division include business development, strategy, finance, project management and development. He is also on the board of Piramal Imaging.SA. Prior to joining Piramal, ...

Corporate Headquarters

247 Business Park
Mumbai, Maharashtra 400083

India

Phone: 91 22 3095 66666
Fax: --

Board Members Memberships

Director
2012-N/A
President of NCE

Education

MBA
Stanford University
BS
Princeton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$550.0K
Samir Uttamlal Mehta M.B.A.Executive Vice Chairman, Managing Director, Member of Securities Transfer & Stakeholders Relationship Committee and Member of Committee of Directors
Torrent Pharmaceuticals Ltd.
$313.0K
Hari Shankar Bhartia Co-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Compensation Committee, Member of Fund Raising Committee, Member of Finance Committee and Member of Sustainability & CSR Committee
Jubilant Life Sciences Limited
--
Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.)Chief Executive Officer, Joint Managing Director and Additional Director
Biocon Limited
--
Murali Krishna Prasad Divi M. Pharm, Ph.D.Chairman, Managing Director and Member of Corporate Social Responsibility Committee
Divi's Laboratories Limited
$9.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Piramal Enterprises Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.